Erika L. Flannery

Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics

Annie N. Cowell, Eva S. Istvan, Amanda K. Lukens et al. · Science · 2018 · 273 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission

David Plouffe, Melanie Wree, Alan Y. Du et al. · Cell Host & Microbe · 2015 · 165 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission

Kelli Kuhen, Arnab K. Chatterjee, Matthias Rottmann et al. · Antimicrobial Agents and Chemotherapy · 2014 · 158 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials

Erika L. Flannery, Case W. McNamara, Sang Wan Kim et al. · ACS Chemical Biology · 2014 · 105 citations

Life Sciences, Molecular Biology, Pharmacology +17

The Plasmodium liver-specific protein 2 (LISP2) is an early marker of liver stage development

Devendra Gupta, Laurent Dembélé, Annemarie Voorberg-van der Wel et al. · eLife · 2019 · 102 citations · Full text

Veterinary Medicine, Molecular Biology, Pharmacology +17